DTs
|
5–1000 days |
Doubling time of sensitive cells |
Fitted to clinical data |
λs
|
ln(2)/DTs[1/day] |
Growth rate of sensitive cells |
Fitted to clinical data |
λr
|
0.5 ·λs[1/day] |
Growth rate of res. cells |
We assume that resistant cells grow twice smaller than sensitive ones |
K |
30 cm diameter |
Carrying capacity |
[17] |
asr
|
0 |
Competition coefficient |
For model calibration we set the parameter to zero (for simplification of the model calibration). In other analyzes we simulated the model for various values of asr.
|
ars
|
0 |
Competition coefficient |
For model calibration we set the parameter to zero (for simplification of the model calibration). In other analyzes we simulated the model for various values of ars.
|
Mdiagnosis
|
4 cm diameter |
Tumor burden at the diagnosis |
[17] |
σ |
0–1 |
Fraction of resistant cells at diagnosis |
Varied |
Mdeath
|
15 cm diameter |
Lethal tumor burden |
[36] |
T |
21 [days] |
Time interval between two consecutive cycles of chemotherapy |
Fitted to clinical data |
k |
0.211 |
Clearance rate of cisplatin |
Half-life of cisplatin is 80 hours |
Cmax
|
20 [A.U.] |
Dose of chemotherapy |
Fitted to clinical data |
CTcycles
|
0–6 |
Number of chemotherapy cycles |
Fitted to clinical data |